Curaleaf (OTCMKTS:CURLF) vs. Glucose Health (OTCMKTS:GLUC) Head-To-Head Survey

Glucose Health (OTCMKTS:GLUC) and Curaleaf (OTCMKTS:CURLF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

Risk and Volatility

Glucose Health has a beta of 3.56, meaning that its stock price is 256% more volatile than the S&P 500. Comparatively, Curaleaf has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.

Valuation & Earnings

This table compares Glucose Health and Curaleaf’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glucose Health	N/A	N/A	N/A	N/A	N/A
Curaleaf	$1.35 billion	1.52	-$281.20 million	($0.39)	-8.08

Glucose Health has higher earnings, but lower revenue than Curaleaf.

Profitability

This table compares Glucose Health and Curaleaf’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	N/A	N/A	N/A
Curaleaf	-20.29%	-14.43%	-5.20%

Insider & Institutional Ownership

0.0% of Curaleaf shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings for Glucose Health and Curaleaf, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Curaleaf	0	0	1	0	3.00

Curaleaf has a consensus target price of $6.25, indicating a potential upside of 98.41%. Given Curaleaf’s higher probable upside, analysts plainly believe Curaleaf is more favorable than Glucose Health.

About Glucose Health

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

About Curaleaf

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.